ReviewJournal of clinical medicine2019
Incidence, Management, Prevention and Outcome of Post-Operative Atrial Fibrillation in Thoracic Surgical Oncology.
Review in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 20 citations in OpenAlex.
- Association between preoperative pan-immune-inflammation value and postoperative atrial fibrillation after scheduled video-assisted thoracoscopic lobectomy.General thoracic and cardiovascular surgery · 2026Article
- Article
- Pulmonary embolism after treatment for massive hemoptysis: a therapeutic dilemma.Respiratory medicine case reports · 2026Article
- Risk prediction models for postoperative atrial fibrillation in patients with lung cancer: a systematic review and meta-analysis.Frontiers in cardiovascular medicine · 2026Review
- Development and validation of a clinical prediction model for postoperative atrial fibrillation after lung cancer surgery: a machine-learning-based study.Frontiers in surgery · 2026Article
- Left atrial appendage occlusion in patients with cancer.Journal of thrombosis and thrombolysis · 2025Review
- Development and internal validation of a nomogram to predict postoperative atrial fibrillation in elderly patients with lung cancer.Journal of thoracic disease · 2025Article
- Article
- Atrial arrhythmias following lung transplantation: A state of the art review.World journal of transplantation · 2025Review
- The Impact of COVID-19 Infection Prior to Lung Resection on Postoperative Complications.Annals of thoracic surgery short reports · 2025Article
- Atrial Fibrillation and Cancer-Epidemiology, Mechanisms, and Management.Journal of clinical medicine · 2024Review
- Crosslink between atrial fibrillation and cancer: a therapeutic conundrum.Cardio-oncology (London, England) · 2024Review
- Review
- Cardiovascular Toxicity and Risk Mitigation with Lung Cancer Treatment.Current oncology reports · 2023Review
- Prevention of new-onset atrial fibrillation in elderly patients undergoing anatomic pulmonary resection by infusion of magnesium sulfate: protocol for a randomized controlled trial.Frontiers in cardiovascular medicine · 2023Article
- Atrial Fibrillation after Lung Cancer Surgery: Prediction, Prevention and Anticoagulation Management.Cancers · 2021Review
- Recurrence of atrial fibrillation following non-cardiac surgery or acute illness: A common but rarely detected complication.International journal of cardiology. Heart & vasculature · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atrial fibrillation (AF) is a common supraventricular arrhythmia, a recognized risk factor for ischemic stroke, as a potential driver for heart failure (HF). Cancer patients have an increased risk for AF, even not including any cancer-specific treatment, as surgery or chemotherapy. The mechanism is multifactorial, with inflammation and changes in autonomic tone as critical actors. Commonly, AF is a recurrent complication of the post-operative period in cancer surgery (especially thoracic). Recent papers confirmed a significant incidence of post-operative (non-cardiac surgery) AF (PAF), partially mitigated by the use of prophylactic (rate o rhythm control) treatments. A relevant difference, in terms of mean hospitalization time, emerges between patients developing PAF and those who do not, while long term impact remains a matter of debate, due to several potential confounding factors. Besides clinical predictors, structural (i.e., echocardiographic) and bio-humoral findings may help in risk prediction tasks. In this respect, pre-operative natriuretic peptides (NPs) concentrations are nowadays recognized as significant independent predictors of perioperative cardiovascular complications (including PAF), while elevated post-operative levels may further enhance risk stratification. The aim of the present paper is to trace the state of the art in terms of incidence, management, prevention, and outcome of PAF in the field of thoracic surgical oncology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.